Tumor susceptibility gene detection

"Tumor susceptibility gene detection" is a tumor warning designed for the Chinese population The chip detection project is to detect the DNA in human blood, and it is found that the genetically determined common high-incidence tumor diseases such as the digestive system, respiratory system, nervous system, endocrine system, and blood system can be detected. It can enable subjects to understand their own genetic information in time, discover or determine whether there is a tumor risk, predict and improve their living environment and habits in advance, and early prevent or treat the existing tumor risk.

ctRNA is an upgrade based on the existing CTC detection technology, and independently developed tumor Ultra-early screening-single-cell transcriptome sequencing ctRNA can accurately determine in situ carcinogenesis. It is unique in China and ranks at the international advanced level. It is a more accurate and reliable early-stage tumor screening technology, which can detect early-stage tumors earlier than traditional detection methods.

Gene ctDNA's original Firefly technology has independent intellectual property rights, and its detection sensitivity and specificity It is an international leader in performance and can realize the rapid industrialization of early cancer gene mutation detection. Liquid biopsy technology can detect early cancers 2-3 years earlier than traditional methods.

Features: